Hrt Financial LP Vertex Pharmaceuticals Inc Transaction History

Hrt Financial LP

$15.7 Billion
Q4 2024

A detailed history of Hrt Financial LP transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Hrt Financial LP holds 10,030 shares of VRTX stock, worth $4.93 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

10,030

Previous 43,297 76.83%

Holding current value

$4.93 Million

Previous $20.1 Million 79.94%

% of portfolio

0.03%

Previous 0.11%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$396.64 - $516.74 $13.2 Million - $17.2 Million	-33,267 Reduced 76.83%	10,030 $4.04 Million
Q3 2024 Nov 12, 2024	SELL	$460.0 - $505.78 $36.9 Million - $40.6 Million	-80,212 Reduced 64.94%	43,297 $20.1 Million
Q2 2024 Aug 12, 2024	BUY	$392.81 - $485.53 $48.5 Million - $60 Million	123,509 New	123,509 $57.9 Million
Q4 2023 Feb 09, 2024	BUY	$343.0 - $410.68 $1.85 Million - $2.22 Million	5,406 Added 212.67%	7,948 $3.23 Million
Q3 2023 Nov 13, 2023	SELL	$338.18 - $362.46 $430,164 - $461,049	-1,272 Reduced 33.35%	2,542 $883,000
Q2 2023 Aug 11, 2023	BUY	$314.42 - $351.91 $1.2 Million - $1.34 Million	3,814 New	3,814 $1.34 Million
Q1 2022 May 16, 2022	SELL	$221.42 - $260.97 $14.1 Million - $16.6 Million	-63,603 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$177.01 - $223.45 $11.3 Million - $14.2 Million	63,603 New	63,603 $14 Million
Q3 2021 Nov 15, 2021	SELL	$181.39 - $202.99 $1.24 Million - $1.39 Million	-6,834 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$187.49 - $221.1 $4.77 Million - $5.63 Million	-25,442 Reduced 78.83%	6,834 $1.38 Million
Q1 2021 May 17, 2021	BUY	$207.02 - $241.31 $6.68 Million - $7.79 Million	32,276 New	32,276 $6.94 Million
Q4 2019 Feb 14, 2020	SELL	$166.71 - $223.91 $1.53 Million - $2.06 Million	-9,191 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$166.23 - $187.09 $1.53 Million - $1.72 Million	9,191 New	9,191 $1.56 Million
Q2 2019 Aug 14, 2019	SELL	$164.61 - $190.37 $1.28 Million - $1.48 Million	-7,768 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$163.73 - $194.7 $392,952 - $467,280	2,400 Added 44.71%	7,768 $1.43 Million
Q2 2018 Aug 15, 2018	BUY	$145.72 - $169.96 $501,713 - $585,172	3,443 Added 178.86%	5,368 $912,000
Q1 2018 May 14, 2018	BUY	$151.6 - $177.13 $291,830 - $340,975	1,925 New	1,925 $313,000

Others Institutions Holding VRTX

# of Institutions

1,757

Shares Held

228M

Call Options Held

1.63M

Put Options Held

1.47M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $126B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.

Account